Chengdu Kanghua Stock Soars 5.96%, Hits Intraday High of CNY 48.69

Chengdu Kanghua Biological Products Co., Ltd. has experienced a notable uptick in its stock performance, gaining 5.96% on July 10, 2026. The stock reached an intraday high of CNY 48.69, marking a significant moment in its trading activity. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.0% on the same day. Despite this daily gain, the company's longer-term performance metrics reveal a more complex picture. Over the past year, Chengdu Kanghua has seen a decline of 23.06%, and its year-to-date performance is down by 34.02%. The stock has also underperformed the China Shanghai Composite over various time frames, including the last three years. Financially, the company reported a net profit of CNY 60.81 million for the first half of the year, reflecting a substantial growth of 188.9%. Additionally, operating cash flow reached a record high of CNY 877.9 million, while raw material costs decreased by 8.7% year-over-year. With a market capitalization of CNY 5,972 million and a return on equity of 6.39%, Chengdu Kanghua continues to navigate a challenging market landscape.